MedTrace Logo

Weight Loss for Obese Individuals With Gout

NCT03664167 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-06-24

No results posted yet for this study

Summary

This study evaluates effect of weight loss in a group of obese patients with gouty arthritis. The study is a randomised group trial where half the patients receive intensive weight loss in the form of meal replacement from Cambridge as well as supervision from a clinical dietician and the other half get usual care.

Conditions

  • Gout, Arthritis, Obesity

Interventions

DIETARY_SUPPLEMENT

intensive weight loss diet, with Cambridge weightplan products, and visits to a dietician.

intensive weight loss diet, with Cambridge weightplan products, and visits to a dietician.

Sponsors & Collaborators

  • Oak Foundation

    collaborator OTHER

  • The Danish Rheumatism Association

    collaborator OTHER

  • Cambridge Weight Plan Limited

    collaborator INDUSTRY

  • Henning Bliddal

    lead OTHER

Principal Investigators

  • Lars Erik Kristensen, MD · CSO The Parker Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2019-11-01
Completion
2019-11-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03664167 on ClinicalTrials.gov